Complement activation directly induced by Helicobacter pylori

Slides:



Advertisements
Similar presentations
Volume 114, Issue 4, Pages (April 1998)
Advertisements

Volume 122, Issue 2, Pages (February 2002)
Volume 134, Issue 1, Pages (January 2008)
Volume 135, Issue 6, Pages e2 (December 2008)
Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response  Miriam Wittmann, MD, Mareike Alter, Tanja.
First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori  Stephan Timm, Marco Sailer, Karl–hermann.
C4 Nephritic Factors in C3 Glomerulopathy: A Case Series
Volume 117, Issue 4, Pages (October 1999)
Volume 116, Issue 2, Pages (February 1999)
“Atypical p-ANCA” in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines  Birgit.
Volume 115, Issue 5, Pages (November 1998)
The role of internal urease in acid resistance of Helicobacter pylori
Gastric cancer, cytotoxin-associated gene A–positive Helicobacter pylori, and serum pepsinogens: An international study  Penelope M. Webb, Jean E. Crabtree,
Volume 123, Issue 2, Pages (August 2002)
Interleukin 15 mediates epithelial changes in celiac disease
PPI-based triple therapy in the eradication of H. pylori infection
Volume 115, Issue 5, Pages (November 1998)
Volume 120, Issue 2, Pages (February 2001)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 122, Issue 4, Pages (April 2002)
Volume 132, Issue 4, Pages (April 2007)
Volume 122, Issue 2, Pages (February 2002)
Volume 122, Issue 5, Pages (May 2002)
Pancreatic acinar cell dysfunction in CFTR−/− mice is associated with impairments in luminal pH and endocytosis  Steven D. Freedman, Horst F. Kern, George.
Volume 120, Issue 2, Pages (February 2001)
Volume 123, Issue 1, Pages (July 2002)
Kinesin is involved in regulation of rat pancreatic amylase secretion
Weibiao Cao, Karen M. Harnett, Jose Behar, Piero Biancani 
Volume 120, Issue 7, Pages (June 2001)
Volume 116, Issue 6, Pages (June 1999)
Volume 119, Issue 1, Pages (July 2000)
Volume 124, Issue 4, Pages (April 2003)
Volume 120, Issue 4, Pages (March 2001)
Volume 59, Issue 1, Pages (January 2001)
Volume 128, Issue 5, Pages (May 2005)
A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b by Hua Zhou, Henrik Olsen, Edward So, Emmanuel.
Volume 118, Issue 6, Pages (June 2000)
Ipe Ninan, Ottavio Arancio  Neuron 
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Volume 121, Issue 4, Pages (October 2001)
Volume 135, Issue 6, Pages e2 (December 2008)
Volume 120, Issue 5, Pages (April 2001)
David R. Scott, Elizabeth A. Marcus, David L. Weeks, George Sachs 
Marina Rektorschek, David Weeks, George Sachs, Klaus Melchers 
Volume 119, Issue 1, Pages (July 2000)
Volume 132, Issue 4, Pages (April 2007)
Volume 67, Issue 2, Pages (February 2005)
Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells  Matthieu Allez, Jens Brimnes, Iris Dotan, Lloyd.
Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats  Jose M. Barrios, Lenard M. Lichtenberger  Gastroenterology 
Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression  Koji Fujimoto, R.Daniel Beauchamp,
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Fleeting Activation of Ionotropic Glutamate Receptors Sensitizes Cortical Neurons to Complement Attack  Zhi-Qi Xiong, James O McNamara  Neuron  Volume.
Volume 125, Issue 4, Pages (October 2003)
Volume 119, Issue 2, Pages (August 2000)
Volume 116, Issue 1, Pages (January 1999)
Joanne L. Tipper, Eileen Ingham, Jonathan H. Cove, Neil J
Volume 121, Issue 5, Pages (November 2001)
Volume 115, Issue 4, Pages (October 1998)
Volume 122, Issue 1, Pages (January 2002)
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation  Tuula Halttunen, Markku.
Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release  J. SjöUlin,
Volume 123, Issue 1, Pages (July 2002)
Interleukin 15 is a potent stimulant of intraepithelial lymphocytes
Ipe Ninan, Ottavio Arancio  Neuron 
Volume 119, Issue 6, Pages (December 2000)
Volume 120, Issue 7, Pages (June 2001)
Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration  Yan Li, John Fung, Feng Lin  Molecular Therapy 
Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are.
Bacterial killing by complement requires membrane attack complex formation via surface‐bound C5 convertases Surface‐bound MAC pores were quantified by.
Volume 114, Issue 1, Pages (January 1998)
Presentation transcript:

Complement activation directly induced by Helicobacter pylori Audun E. Berstad, Kolbjørn Høgåsen, Geir Bukholm, Anthony P. Moran, Per Brandtzaeg  Gastroenterology  Volume 120, Issue 5, Pages 1108-1116 (April 2001) DOI: 10.1053/gast.2001.23248 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 Two cagA+ and 2 cagA− strains of H. pylori, Zymosan A, or saline (negative control) were incubated with nonimmune human serum for different time intervals at 37°C before complement activation was blocked by the addition of EDTA. The complement activation products (A) C3bc and (B) TCC were subsequently measured. Mean ± SD of 3 representative experiments are indicated. Concentrations of complement products are given as AU/mL. After 15 minutes, H. pylori generated significantly more C3bc (P = 0.01), but less TCC (P = 0.004), than Zymosan. Gastroenterology 2001 120, 1108-1116DOI: (10.1053/gast.2001.23248) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 2 Levels of (A) C3bc and (B) TCC generated after incubation of H. pylori with preabsorbed nonimmune human serum. Classic pathway activation, or both classic and alternative pathway activation, were blocked by adding EGTA-Cl2 or EDTA, respectively, before incubations as indicated. Zymosan A (OD 0.8 and 10 mg/mL) was included as control for alternative pathway activation, and HAIGG (1 mg/mL) as control for the classic pathway. Saline served as negative control. Each column represents mean ± SD of 4 separate experiments. *P < 0.01 for reduction of activation by EGTA-Cl2. Gastroenterology 2001 120, 1108-1116DOI: (10.1053/gast.2001.23248) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 3 Complement activation by smooth LPS in nonimmune human serum. (A) C3bc and (B) TCC were generated in a dose-dependent manner. Mean ± SD of 5 separate experiments is plotted. *P < 0.01 for reduction of activation by EGTA-Cl2. Gastroenterology 2001 120, 1108-1116DOI: (10.1053/gast.2001.23248) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 4 Serum sensitivity of H. pylori (strain L01) after 15-minute contact with nonimmune (■) or heat-inactivated (○; 56°C, 30 minutes) nonimmune human serum at various concentrations as indicated. Serum sensitivity of type strain NCTC 11637 (▾) after contact with nonimmune human serum is shown for comparison. The number of bacterial colonies is given in percentage of that obtained after incubation with medium alone (100% reference). Mean ± SD of 5 separate experiments is plotted. *P < 0.001 for increase in number of colonies of strain L01 after heat inactivation of serum. Gastroenterology 2001 120, 1108-1116DOI: (10.1053/gast.2001.23248) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 5 Two-color immunofluorescence staining (double exposures) of complement deposits on H. pylori after incubation with preabsorbed nonimmune human serum for 5 minutes. (A) Paired staining for C3bc (Texas red) and H. pylori (FITC, green) shows colocalization (yellow), signifying the presence of C3bc on several of the bacteria. (B) Paired staining for TCC (Texas red) and H. pylori (FITC) likewise shows colocalization (yellow), signifying terminal complement activation with the formation of the membrane attack complex (or TCC). Bacteria associated with complement activation appear swollen, suggesting lytic activity. (C) The bacteria appear rod shaped and do not stain for C3bc after blocking of complement activation with EDTA before bacterial incubation (staining protocol as in A; original magnification, 1000×). Gastroenterology 2001 120, 1108-1116DOI: (10.1053/gast.2001.23248) Copyright © 2001 American Gastroenterological Association Terms and Conditions